Abstract
Peritoneal mesothelioma is a rare form of malignant mesothelioma, making up <30% of diagnosed mesothelioma cases. Because of a lack of specific symptoms (abdominal pain, abdominal swelling), normally it is diagnosed in advanced stages, sometimes in a surgical emergency (intestinal obstruction, severe ascites) and occasionally during image procedures or laparoscopy which can show a mass developing from peritoneal mesothelium surfaces, or an accumulation of small irregularities that may be tumors or plaques. The reported case refers to a particular localization of a peritoneal mesothelioma, the spleen, discovered only after a splenectomy, due to the clinical and radiological suspect of a rupture.
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Cisplatin / administration & dosage
-
Deoxycytidine / administration & dosage
-
Deoxycytidine / analogs & derivatives
-
Gemcitabine
-
Humans
-
Laparoscopy*
-
Male
-
Mesothelioma / diagnostic imaging
-
Mesothelioma / drug therapy
-
Mesothelioma / secondary
-
Mesothelioma / surgery*
-
Middle Aged
-
Neoplasm Grading
-
Neoplasm Recurrence, Local*
-
Peritoneal Neoplasms / diagnostic imaging
-
Peritoneal Neoplasms / drug therapy
-
Peritoneal Neoplasms / pathology
-
Peritoneal Neoplasms / surgery*
-
Radiography
-
Splenectomy* / methods
-
Splenic Neoplasms / diagnostic imaging
-
Splenic Neoplasms / drug therapy
-
Splenic Neoplasms / secondary
-
Splenic Neoplasms / surgery*
-
Time Factors
-
Treatment Failure
Substances
-
Deoxycytidine
-
Cisplatin
-
Gemcitabine